IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

Journal of Autoimmunity

Volumn 27, Issue 1, 2006, Pages 50-53

  Aoki, Christopher A ^a   Roifman, Chaim M ^b   Lian, Zhe Xiong ^a   Bowlus, Christopher L ^a   Norman, Gary L ^c   Shoenfeld, Yehuda ^d   Mackay, Ian R ^e   Eric Gershwin, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NOVA Diagnostics Inc   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Allogenic stem cell transplant; CD4+ CD25+ T regulatory cells; IL 2 receptor alpha deficiency; Molecular mimicry; Pediatric; Primary biliary cirrhosis

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ARTICLE; AUTOIMMUNITY; CASE REPORT; CD4+ T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SEROLOGY; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA;

AUTOIMMUNITY; CHILD, PRESCHOOL; CONSANGUINITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER CIRRHOSIS, BILIARY; MALE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 33747763675     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.04.005     Document Type: Article

References (26)

1. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
2. Gershwin M.E., Mackay I.R., Sturgess A., and Coppel R.L. Identification and specificity of a cDNA encoding the 70 kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138 (1987) 3525-3531
3. Gershwin M.E., Ansari A.A., Mackay I.R., Nakanuma Y., Nishio A., Rowley M.J., et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 174 (2000) 210-225
4. Christensen E., Crowe J., Doniach D., Popper H., Ranek L., Rodes J., et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 78 (1980) 236-246
5. Talwalkar J.A., and Lindor K.D. Primary biliary cirrhosis. Lancet 362 (2003) 53-61
6. Szostecki C., Krippner H., Penner E., and Bautz F.A. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 68 (1987) 108-116
7. Sternsdorf T., Guldner H.H., Szostecki C., Grotzinger T., and Will H. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42 (1995) 257-268
8. Courvalin J.C., Lassoued K., Bartnik E., Blobel G., and Wozniak R.W. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 86 (1990) 279-285
9. Wesierska-Gadek J., Hohenuer H., Hitchman E., and Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110 (1996) 840-847
10. Dahlan Y., Smith L., Simmonds D., Jewell L.D., Wanless I., Heathcote E.J., et al. Pediatric-onset primary biliary cirrhosis. Gastroenterology 125 (2003) 1476-1479
11. Danielsson A., Boqvist L., and Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 11 (1990) 458-464
12. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42 (2005) 1194-1202
13. Kim W.R., Lindor K.D., Locke III G.R., Therneau T.M., Homburger H.A., Batts K.P., et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119 (2000) 1631-1636
14. Lofgren J., Jarnerot G., Danielsson D., and Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 20 (1985) 647-650
15. Myszor M., and James O.F. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?. Q J Med 75 (1990) 377-385
16. Selmi C., Invernizzi P., Keeffe E.B., Coppel R.L., Podda M., Rossaro L., et al. Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 38 (2004) 264-271
17. Watson R.G., Angus P.W., Dewar M., Goss B., Sewell R.B., and Smallwood R.A. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 36 (1995) 927-930
18. Witt-Sullivan H., Heathcote J., Cauch K., Blendis L., Ghent C., Katz A., et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 12 (1990) 98-105
19. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94 (1997) 3168-3171
20. Moteki S., Leung P.S., Coppel R.L., Dickson E.R., Kaplan M.M., Munoz S., et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24 (1996) 97-103
21. Feldstein A.E., Perrault J., El-Youssif M., Lindor K.D., Freese D.K., and Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 38 (2003) 210-217
22. Fehervari Z., and Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 114 (2004) 1209-1217
23. Chuang Y.H., Lian Z.X., Cheng C.M., Lan R.Y., Yang G.X., Moritoki Y., et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25 (2005) 126-132
24. Minasi L.E., Kamogawa Y., Carding S., Bottomly K., and Flavell R.A. The selective ablation of interleukin 2-producing cells isolated from transgenic mice. J Exp Med 177 (1993) 1451-1459
25. Lan R.Y., Cheng C., Lian Z.-X., Tsuneyama K., Yang G.-X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatol 43 (2006) 729-737
26. Burt R.K., Verda L., Oyama Y., Statkute L., and Slavin S. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 26 (2004) 57-69